skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

44 Total results for product and free and sample content found

Trialtrove

First for Fatty Liver – Who will win the race to be the first NAFLD treatment to market?

By Ethan Hebert 19 Apr 2017

Currently there are no approved pharmacological treatments for non-alcoholic fatty liver disease (NAFLD), including the subtype non-alcoholic steatohepatitis (NASH).

Topic Clinical trials

Sitetrove

How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial

By Loni Branon 24 Mar 2017

Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.

Topic Clinical trials

Sitetrove

How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial

By Loni Branon 24 Mar 2017

Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.

Topic Clinical trials

Trialtrove

Strategies To Maintain Top Positions In Autoimmune and Inflamation

By Pamela Spicer 22 Mar 2017

A Steady Course: Strategies to Maintain Top Positions in Autoimmune/ Inflammation

Pharmaprojects, Biomedtracker, Trialtrove

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

By Rachel Meighan-Mantha 22 Mar 2017

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

Topic Cancer Clinical trial optimization

Pharmaprojects

Statins forever: Is anything set to topple this class’s mighty reign?

By Andrew Frost 22 Mar 2017

With the recent controversy surrounding the approval and launch of the first wave of PCSK9 inhibitors (focussing mainly on the extremely high cost in comparison to statin therapies), it may be easy to forget that the dyslipidaemia space has also been plagued by a number of high profile and costly failures too.

Topic Drug development landscape

Trialtrove

Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma

By Laura Runkel 17 Jan 2017

After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized? After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized?

Trialtrove

Kinase inhibitors in rheumatoid arthritis: where have they been and where are they going?

By ​Gunilla Sturrock 07 Dec 2016

This analysis provides a five year review of the RA kinase inhibitor programs – where have they been and where are they going.

Topic Clinical trial optimization

Trialtrove

2016 Clinical trials roundup: Steady Course or changing tides?

By Doro Shin 07 Dec 2016

Welcome to this year’s roundup where we’ll review clinical trials that initiated in 2015 to elucidate any ongoing, or new, trends within the world of pharma R&D.

Topic Clinical trials

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: